NPPA issued a notification regarding the fixation of retail price of Sitagliptin

Nov 28, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on November 25, 2024, issued a notification regarding the fixation of the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 1000 mg (as sustained release).

The following has been stated: -

•For each Film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg + Metformin Hydrochloride IP 1000 mg (as sustained release) for M/s Pure & Cure Health Care Pvt Ltd (Manufacturer) and M/s Primus Remedies Pvt Ltd (Marketer)the retail price is 0.83.

The detailed notification is given in the document attached below.

[Notification No. 19(4272)/2024/DP/NPPA/DIV.II] 


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT